Abstract:The Cancer Proteome Atlas (TCPA) project collects reverse-phase protein arrays (RPPA)-based proteome datasets from nearly 8000 samples across 32 cancer types. This study aims to investigate the pan-cancer proteome signature and identify cancer subtypes of glioma, kidney cancer, and lung cancer based on TCPA data. We first visualized the tumor clustering models using t-distributed stochastic neighbour embedding (t-SNE) and biclustering heatmap. Then, three feature selection methods (pyHSICLasso, XGBoost, and Random Forest) were performed to select protein features for classifying cancer subtypes in training dataset, and the LibSVM algorithm was empolyed to test classification accuracy in the validation dataset. Clustering analysis revealed that different kinds of tumors have relatively distinct proteomic profiling based on tissue or origin. We identified 20, 10, and 20 protein features with the highest accuracies in classifying subtypes of glioma, kidney cancer, and lung cancer, respectively. The predictive abilities of the selected proteins were confirmed by receiving operating characteristic (ROC) analysis. Finally, the Bayesian network was utilized to explore the protein biomarkers that have direct causal relationships with cancer subtypes. Overall, we highlight the theoretical and technical applications of machine learning based feature selection approaches in the analysis of high-throughput biological data, particularly for cancer biomarker research. Significance: Functional proteomics is a powerful approach for characterizing cell signaling pathways and understanding their phenotypic effects on cancer development. The TCPA database provides a platform to explore and analyze TCGA pan-cancer RPPA-based protein expression. With the advent of the RPPA technology, the availability of high-throughput data in TCPA platform has made it possible to use machine learning methods to identify protein biomarkers and further differentiate subtypes of cancer based on proteomic data. In this study, we highlight the role of feature selection and Bayesian network in discovery protein biomarker for classifying cancer subtypes based on functional proteomic data. The application of machine learning methods in the analysis of high-throughput biological data, particularly for cancer biomarker researches, which have potential clinical values in developing individualized treatment strategies.

Informative Gene Selection for Cancer Subtype Classification with BP Neural Networks

Tumor Informative Genes Selection Based on BP Neural Networks

Cancer Subtype Recognition and Feature Selection with Gene Expression Profiles

Using feature selection and Bayesian network identify cancer subtypes based on proteomic data

Selection of Feature Genes in Cancer Clsssification

Neighborhood Rough Set Model Based Gene Selection for Multi-subtype Tumor Classification

Gene Selection and Cancer Classification Using A Fuzzy Neural Network

Study of Informative Gene Selection for Tissue Classification Based on Tumor Gene Expression Profiles

Multi-class Tumor Subtype Recognition Based on Neural Networks

Cancer Informative Gene Identification Based on Statistical Method

Gene Selection for Leukemia Subtype Classification from Gene Expression Profile

Subtype Dependent Biomarker Identification and Tumor Classification from Gene Expression Profiles.

A Method for Cancer Classification Using Ensemble Neural Networks with Gene Expression Profile

A Novel Method for Gene Selection and Cancer Classification

Tumor Diagnosis System Based on Information Entropy and Artificial Neural Networks

A method for informative gene selection using neighborhood uncertainty and scoring criteria

SRBCTs Subtype Recognition Based on Gene Expression Profiles

Analysis of Gene Sensitivity for Tumor Informative Genes Selection Based on SVM

An Effective Gene Selection Method for Cancer Subtype Classification Based on Predatory Search Genetic Algorithm and Support Vector Machine

Finding minimum gene subsets with heuristic breadth-first search algorithm for robust tumor classification

Feature (gene) Selection in Gene Expression-Based Tumor Classification